There Are Three Things Driving Amplify’s 5.1%. Yield Higher | IDVO

Core Viewpoint - The Amplify CWP International Enhanced Dividend Income ETF (IDVO) utilizes a multi-source income strategy, primarily focusing on American Depositary Receipts (ADRs), which allows U.S. investors to access international dividend yields that often exceed those of U.S. companies, particularly in sectors like pharmaceuticals and banking [3][6][11]. Group 1: Fund Structure and Income Sources - IDVO draws income from three sources: dividends from ADR holdings, covered call premiums, and capital appreciation, differentiating it from traditional income funds [5][7]. - The fund's net expense ratio is 0.65%, and it has surpassed $1 billion in assets under management since its inception in September 2022 [8]. - As of January 31, 2026, IDVO reported a distribution rate of 6.17%, but the 30-day SEC yield was only 1.49%, indicating that a significant portion of distributions is a return of capital rather than earned income [8][10]. Group 2: Currency Sensitivity and Dividend Growth - IDVO's income is sensitive to currency fluctuations, as ADR dividends are converted from foreign currencies, which can impact the dollar amount received by investors [2][16]. - Novartis, a key holding at 3.9% of the portfolio, has shown consistent dividend growth, with payments increasing from $2.43 in 2013 to $4.77 in 2026, alongside a one-year share price return of 36% [11]. Group 3: Return of Capital and Tax Implications - Approximately 77% of IDVO's February 2026 distribution was a return of capital, which reduces the cost basis over time and can complicate tax implications for investors [9][14]. - The distinction between earned income and return of capital is crucial for tax planning, especially for investors in higher tax brackets [14][16].